Circulating BRAF(V600E) Levels Correlate with Treatment in Patients with Thyroid Carcinoma

Background: BRAF(V600E) is the most common mutation in papillary thyroid carcinoma (PTC) and can be associated with aggressive disease. Previously, a highly sensitive blood RNA-based BRAF(V600E) assay was reported. The objective of this study was to assess the correlation of BRAF(V600E) circulating...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Thyroid
Päätekijät: Lubitz, Carrie C., Zhan, Tiannan, Gunda, Viswanath, Amin, Salma, Gigliotti, Benjamin J., Fingeret, Abbey L., Holm, Tammy M., Wachtel, Heather, Sadow, Peter M., Wirth, Lori J., Sullivan, Ryan J., Panka, David J., Parangi, Sareh
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Mary Ann Liebert, Inc. 2018
Aiheet:
Thyroid Cancer and Nodules
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865613/
https://ncbi.nlm.nih.gov/pubmed/29378474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/thy.2017.0322
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia